Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Diagnostic Cytopathology
|
July 31, 2021
Non-neoplastic inflammatory pseudotumor of the lung after immunotherapy for melanoma: A diagnostic pitfall on fine needle aspiration biopsy of lung
Blessie Elizabeth Nelson, Angelina Hong, Ike Okereke, et al.
NPJ Precision Oncology
|
May 25, 2023
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma
Blessie Elizabeth Nelson, Neha K Reddy, Jason T Huse, et al.
The Oncologist
|
June 13, 2023
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors
Blessie Elizabeth Nelson, Apostolia M Tsimberidou, Xueyao Fu, et al.
Journal of Hematology
|
July 15, 2022
Spectrum of Immune Checkpoint Inhibitor Anemias: Results From a Single Center, Early-Phase Clinical Trials Case Series Experience
Blessie Elizabeth Nelson, Chinenye Lynette Ejezie, Bettzy A Stephen, et al.
Molecular Cancer
|
March 27, 2024
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study
Blessie Elizabeth Nelson, Jason Roszik, Jibran Ahmed, et al.
NPJ Precision Oncology
|
February 21, 2023
BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study
Blessie Elizabeth Nelson, Jason Roszik, Filip Janku, et al.
The Oncologist
|
March 23, 2023
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience
Mirella Nardo, Bulent Yilmaz, Blessie Elizabeth Nelson, et al.
Cancer
|
April 5, 2023
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer
Blessie Elizabeth Nelson, Sadia Saleem, Senthil Damodaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2025
Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors
Blessie Elizabeth Nelson, Filip Janku, Siqing Fu, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Diagnostic Cytopathology
|
July 31, 2021
Non-neoplastic inflammatory pseudotumor of the lung after immunotherapy for melanoma: A diagnostic pitfall on fine needle aspiration biopsy of lung
Blessie Elizabeth Nelson, Angelina Hong, Ike Okereke, et al.
NPJ Precision Oncology
|
May 25, 2023
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma
Blessie Elizabeth Nelson, Neha K Reddy, Jason T Huse, et al.
The Oncologist
|
June 13, 2023
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors
Blessie Elizabeth Nelson, Apostolia M Tsimberidou, Xueyao Fu, et al.
Journal of Hematology
|
July 15, 2022
Spectrum of Immune Checkpoint Inhibitor Anemias: Results From a Single Center, Early-Phase Clinical Trials Case Series Experience
Blessie Elizabeth Nelson, Chinenye Lynette Ejezie, Bettzy A Stephen, et al.
Molecular Cancer
|
March 27, 2024
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study
Blessie Elizabeth Nelson, Jason Roszik, Jibran Ahmed, et al.
NPJ Precision Oncology
|
February 21, 2023
BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study
Blessie Elizabeth Nelson, Jason Roszik, Filip Janku, et al.
The Oncologist
|
March 23, 2023
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience
Mirella Nardo, Bulent Yilmaz, Blessie Elizabeth Nelson, et al.
Cancer
|
April 5, 2023
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer
Blessie Elizabeth Nelson, Sadia Saleem, Senthil Damodaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2025
Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors
Blessie Elizabeth Nelson, Filip Janku, Siqing Fu, et al.
Page
of 2